Target intelligence / Profile preview

No conventional molecular drug target

Molecular classification
Other
01

Overview

The designation "No conventional molecular drug target" is utilized in pharmacological classification to identify therapeutic agents whose primary mode of action does not involve binding to a specific protein, such as a receptor, enzyme, or ion channel (ChEMBL Database, 2024). These agents typically exert their effects through broad physical or chemical interactions within the physiological environment. For example, antacids like aluminum hydroxide work by directly neutralizing gastric hydrochloric acid to mitigate acidity (StatPearls, 2023). Osmotic laxatives and diuretics, such as polyethylene glycol and mannitol, function by altering osmotic pressure to facilitate fluid movement (PubChem, 2024). Additionally, adsorbents like activated charcoal provide a large surface area to physically trap toxins, preventing their systemic absorption (StatPearls, 2023). Because these substances lack a discrete molecular binding site, they are generally not subject to traditional structure-based drug design or target-validation studies.

Other names
Non-specific mechanismPhysicochemical mechanismNon-molecular targetNon-protein target
02

Mechanism of action

Physical or chemical interactions including neutralization, osmosis, adsorption, and surface tension modification.

03

Biological functions

Other
04

Disease associations

Gastrointestinal disordersPoisoningEdemaConstipationAcid reflux
05

Safety considerations

Electrolyte imbalanceDehydrationInterference with absorption of other drugsSystemic toxicity from non-absorbable components
06

Interacting drugs

Aluminum hydroxide

8 more in the full profile.

Beyond the preview

Go deeper on No conventional molecular drug target.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on No conventional molecular drug target.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call